Latham & Watkins represented IDEAYA, while Davis Polk advised the representatives of the several underwriters in the offering.IDEAYA Biosciences, Inc. (Nasdaq: IDYA) announced the pricing of an underwritten…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
